Akums Drugs & Pharma Complete Financial Statements
AKUMS • Review detailed financials to uncover trends, confirm thesis & journal trades
8 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Akums Drugs & Pharma (AKUMS).
Downloads include all available records across all periods.
For market performance, see the
AKUMS stock price today
.
Profitability Ratios
Net Profit Margin
4.10%
2025 data
EBITDA Margin
12.10%
2025 data
Operating Margin
9.00%
2025 data
Return on Assets
1.05%
2025 data
Return on Equity
1.40%
2025 data
Balance Sheet Ratios
Current Ratio
14.58
2025 data
Debt to Equity
1.34
2025 data
Equity Ratio
74.50%
2025 data
Asset Turnover
0.26
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Net Profit Growth
-35.8%
Year-over-Year
EBITDA Growth
-8.0%
Year-over-Year
Expense Growth
+1.2%
Year-over-Year
Assets Growth
+17.0%
Year-over-Year
Equity Growth
+325.0%
Year-over-Year
Liabilities Growth
+17.0%
Year-over-Year
Operating Cash Flow Growth
-6.6%
Year-over-Year
Investing Cash Flow Growth
-65.6%
Year-over-Year
Financing Cash Flow Growth
+167.6%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Jun 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,050 | 1,081 | 1,051 | 1,050 | 955 | 1,026 | 1,030 | 1,188 | 978 | 1,093 |
| Expenses | 923 | 962 | 895 | 912 | 941 | 891 | 889 | 1,057 | 1,095 | 989 |
| EBITDA | 127 | 120 | 156 | 138 | 14 | 135 | 141 | 131 | -117 | 103 |
| Operating Profit Margin % | 9.00% | 9.00% | 13.00% | 12.00% | 0.00% | 13.00% | 12.00% | 11.00% | -13.00% | 9.00% |
| Depreciation | 38 | 40 | 37 | 35 | 34 | 34 | 45 | 30 | 30 | 32 |
| Interest | 23 | 5 | 23 | 12 | 12 | 13 | 5 | 14 | 12 | 12 |
| Profit Before Tax | 66 | 75 | 96 | 92 | -33 | 88 | 91 | 87 | -159 | 59 |
| Tax | 23 | -75 | 31 | 25 | 7 | 26 | 25 | 54 | 29 | -136 |
| Net Profit | 43 | 150 | 65 | 67 | -40 | 61 | 66 | 33 | -187 | 195 |
| Earnings Per Share (₹) | 2.66 | 9.64 | 4.15 | 4.37 | -2.89 | 4.21 | 4.26 | 2.22 | -13.16 | 13.21 |
Related Pages for Akums Drugs & Pharma
Additional stock information and data for AKUMS
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 4,113 | 3,516 | 3,267 | 3,069 | 2,192 | 2,078 |
| Current Assets | 2,275 | 1,941 | 1,879 | 1,864 | 1,157 | 1,250 |
| Fixed Assets | 1,397 | 1,191 | 1,097 | 1,021 | 834 | 645 |
| Capital Work in Progress | 163 | 195 | 103 | 31 | 87 | 57 |
| Investments | 0 | 0 | 0 | 0 | 19 | 6 |
| Other Assets | 2,553 | 2,130 | 2,066 | 2,017 | 1,252 | 1,371 |
| LIABILITIES | ||||||
| Total Liabilities | 4,113 | 3,516 | 3,267 | 3,069 | 2,192 | 2,078 |
| Current Liabilities | 156 | 1,585 | 1,278 | 1,172 | 725 | 627 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 3,064 | 721 | 723 | 625 | 887 | 721 |
| Share Capital | 31 | 29 | 29 | 14 | 1 | 1 |
| Reserves & Surplus | 3,016 | 681 | 689 | 608 | 884 | 721 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 465 | 498 | 177 | 32 | 135 | 28 | 89 | 72 |
| Investing Activities | -548 | -331 | -305 | -235 | -109 | -190 | -123 | -150 |
| Financing Activities | 73 | -108 | 125 | 236 | -95 | 233 | 37 | 66 |
| Net Cash Flow | -10 | 59 | -4 | 33 | -70 | 71 | 4 | -11 |